Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Magdeburg
Clinical trial register · Germany

Clinical Trials in Magdeburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
BioMarin Pharmaceutical5 AstraZeneca5 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company5 Bristol-Myers Squibb4 Pfizer4
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Magdeburg

94 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
Juan Carlos M. Andreani MD
Not applicable
40
Magdeburg
2027-06-01
Not yet open
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
NCT07873931Systemic Lupus Erythematosus, Sjögren's Disease, Rheumatoid Arthritis, Idiopathic Inflammatory Myopathies
Bristol-Myers Squibb
Phase 1
60
Berlin, Erlangen, Magdeburg, Würzburg
2026-10-30
Not yet open
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
52
Magdeburg, Erlangen
2026-08-31
Recruiting
argenx
Phase 3
230
Magdeburg
2026-06-10
Recruiting
Camurus AB
Observational
200
Aachen, Leipzig, Magdeburg, München, Würzburg
2026-06-05
Not yet open
Novo Nordisk A/S
Phase 3
1,000
Bad Oeynhausen, Elsterwerda, Essen, Fulda, Hamburg, Lingen, Magdeburg, Osnabrück
2026-05-20
Recruiting
Ipsen
Phase 3
350
Berlin, Dresden, Hanover, Heidelberg, Leipzig, Magdeburg, Mainz, Tübingen
2026-05-14
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Aachen, Bonn, Essen, Frankfurt, Hanover, Heidelberg, Kiel, Magdeburg
2026-04-21
Recruiting
Bristol-Myers Squibb
Phase 3
850
Augsburg, Erlangen, Koblenz, Ludwigshafen am Rhein, Magdeburg, Kiel, Jena, Berlin
2026-03-16
Recruiting
Novo Nordisk A/S
Phase 3
1,150
Bad Oeynhausen, Elsterwerda, Fulda, Magdeburg, Osnabrück, Witten
2026-02-24
Recruiting
AstraZeneca
Phase 1
24
Leipzig, Magdeburg, Würzburg
2025-12-09
Recruiting
ARTICE® Real Data Collection & Observational Trial, Phase 4 Study
NCT07388628Sepsis, Septic Shock, Immunoparalysis in Septic Shock
Artcline GmbH
Observational
200
Magdeburg, Minden
2025-09-25
Recruiting
Pfizer
Phase 3
400
Ravensburg, Ulm, Augsburg, Erlangen, Essen, Magdeburg, Berlin, Hamburg
2025-08-05
Recruiting
BioMarin Pharmaceutical
Phase 2
60
Cologne, Homburg, Magdeburg
2025-07-30
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
89
Leipzig, Magdeburg, Berlin, Cologne, Erlangen, Herne
2025-07-14
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Berlin, Cologne, Dresden, Göttingen, Hanover, Heidelberg, Leipzig, Magdeburg
2025-07-02
By invitation
BioMarin Pharmaceutical
Phase 3
140
Homburg, Cologne, Magdeburg
2025-06-20
Recruiting
Immunovant Sciences GmbH
Phase 3
231
Bochum, Goettigen, Magdeburg, Würzburg
2025-05-27
Recruiting
EURO-STIM Registry
NCT06971796Obstructive Sleep Apnea, Obstructive Sleep Apnea (OSA)
Inspire Medical Systems, Inc.
Observational
1,000
Hamburg, Lübeck, Magdeburg, Mannheim, Munich
2025-05-26
Recruiting
Novartis Pharmaceuticals
Phase 2
224
Frankfurt am Main, Mainz, Bad Bentheim, Dresden, Hamburg, Heidelberg, Magdeburg, Münster
2025-05-16
Recruiting
Takeda
Phase 3
225
Bonn, Düsseldorf, Leipzig, Halle, Magdeburg, Berlin
2025-05-06
Recruiting
AstraZeneca
Phase 1
72
Cologne, Erlangen, Magdeburg
2025-05-01
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Magdeburg, Berlin, Deggingen
2025-04-09
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Munich, Hanover, Chemnitz, Leipzig, Magdeburg, Kiel, Berlin, Hamburg
2025-03-12
Active, closed
Takeda
Phase 3
601
Leipzig, Magdeburg, Berlin, Hamburg, Herne
2025-03-10
Recruiting
Hoffmann-La Roche
Phase 2
130
Berlin, Cologne, Magdeburg
2025-03-05
Active, closed
GlaxoSmithKline
Phase 2
307
Bendorf, Berlin, Darmstadt, Frankfurt, Fürstenwalde, Leipzig, Magdeburg, Mainz
2025-02-10
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Bochum, Frankfurt am Main, Hamburg, Hanover, Heilbronn, Magdeburg, Riesa, Ulm
2024-12-13
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 3
649
Ahrensburg, Bendorf, Berlin, Delitzsch, Frankfurt, Leipzig, Magdeburg, Mainz
2024-12-12
Active, closed
Incyte Corporation
Phase 3
346
Aachen, Buxtehude, Chemnitz, Darmstadt, Dresden, Frankfurt am Main, Göttingen, Magdeburg
2024-10-10
Recruiting
Kyverna Therapeutics
Phase 2/3
66
Berlin, Bochum, Hamburg, Hanover, Jena, Magdeburg, Munich
2024-08-28
Recruiting
MB-CART19.1 in Refractory SLE
NCT06189157SLE - Systemic Lupus Erythematosus
DrugMB-CART19.1
Miltenyi Biomedicine GmbH
Phase 1/2
29
Erlangen, Magdeburg, Tübingen
2024-08-12
Active, closed
Study Protocol for a Pilot Randomized Controlled Trial of a Psychosocial Care Intervention in Intensive Care
NCT06733493Psychosocial Intervention, Intensive Care Units (ICUs), Psychosocial Health
Harald Gündel
Not applicable
375
Ulm, Magdeburg, Berlin
2024-08-01
Recruiting
Managing Congestion in Heart Failure: A Mechanistic Study in Patients With HFpEF
NCT06977477Heart Failure With Preserved Ejection Fraction, Remote Monitoring in Heart Failure
Otto-von-Guericke University Magdeburg
Not applicable
20
Magdeburg
2024-06-18
Active, closed
BioMarin Pharmaceutical
Phase 3
80
Cologne, Magdeburg
2024-06-17
Recruiting
Boris Böll
Observational
400
Cologne, Dessau, Essen, Frankfurt am Main, Leipzig, Magdeburg
2024-06-05
Active, closed
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
120
Essen, Magdeburg, Düsseldorf, Erlangen, München
2024-03-28
Active, closed
Real World Use of Tocilizumab Biosimilar studY
NCT06247722Rheumatoid Arthritis
Fresenius Kabi SwissBioSim GmbH
Observational
600
Berlin, Halle, Ludwigsfelde, Magdeburg, Naumburg, Planegg, Potsdam, Templin
2024-03-05
Active, closed
Genmab
Phase 3
1,095
Karlsruhe, Frankfurt am Main, Kassel, Eschweiler, Ludwigshafen am Rhein, Magdeburg
2024-02-05
Active, closed
Janssen Research & Development, LLC
Phase 3
838
Augsburg, Halle, Heidelberg, Magdeburg, München, Tübingen, Würzburg
2024-01-22
Recruiting
Artcline GmbH
Observational
142
Magdeburg, Rostock
2024-01-01
Recruiting
BioMarin Pharmaceutical
Observational
400
Cologne, Magdeburg
2023-11-27
Active, closed
Pfizer
Phase 3
1,571
Darmstadt, Bielefeld, Bochum, Bonn, Mainz, Dresden, Leipzig, Magdeburg
2023-11-08
Active, closed
AstraZeneca
Phase 1/2
166
Magdeburg, Neu-Ulm, Neuss
2023-09-29
Active, closed
Hoffmann-La Roche
Phase 3
687
Esslingen am Neckar, Magdeburg, Mainz, Tübingen
2023-09-14
Active, closed
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)
NCT05869955Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathy, Systemic Sclerosis, Rheumatoid Arthritis
DrugsZola-cel·Tocilizumab·Fludarabine·Cyclophosphamide
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1
270
Würzburg, Cologne, Leipzig, Magdeburg, Berlin, Düsseldorf, Erlangen
2023-09-13
Recruiting
Chinese Academy of Sciences
Not applicable
400
Magdeburg
2023-08-29
Recruiting
Pfizer
Phase 2
340
Bad Bentheim, Mainz, Magdeburg
2023-08-22
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Augsburg, Hanover, Mainz, Trier, Magdeburg, Jena, Essen
2023-07-06
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
125
Magdeburg, Berlin, Bochum, Chemnitz, Düsseldorf, Erlangen, Essen, Halle
2023-03-20
Active, closed
Electrical Stimulation for the Treatment of Glaucoma
NCT05626491Glaucoma, Glaucoma, Open-Angle
Stanford University
Not applicable
45
Magdeburg
2023-02-28
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Hamburg, Lübeck, Magdeburg
2023-01-10
Recruiting
Pfizer
Phase 4
210
Tübingen, Magdeburg, Berlin
2022-07-05
Active, closed
Hanmi Pharmaceutical Company Limited
Phase 2
17
Magdeburg
2022-05-05
Active, closed
Setrusumab vs Placebo for Osteogenesis Imperfecta
NCT05125809Osteogenesis Imperfecta
DrugSetrusumab
Ultragenyx Pharmaceutical Inc
Phase 2/3
183
Cologne, Magdeburg, Würzburg
2022-02-21
Recruiting
University of Melbourne
Phase 4
8,000
Berlin, Dresden, Freiburg im Breisgau, Magdeburg
2022-02-16
Active, closed
JOTEC GmbH
Observational
108
Hanover, Magdeburg
2021-10-20
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
333
Chemnitz, Frankfurt, Hanover, Kiel, Leipzig, Magdeburg, Münster, Tübingen
2021-09-22
Active, closed
AstraZeneca
Phase 3
712
Bielefeld, Bochum, Cologne, Düsseldorf, Giessen, Hanover, Herne, Magdeburg
2021-08-05
Active, closed
Bristol-Myers Squibb
Phase 3
729
Ratingen, Cologne, Erlangen, Hamburg, Magdeburg, Minden, Tübingen
2021-07-15
Recruiting
Corcym S.r.l
Observational
2,150
Augsburg, Bad Nauheim, Berlin, Dresden, Essen, Magdeburg, Nuremberg, Oldenburg
2021-06-29
Active, closed
Neurocrine Biosciences
Phase 3
103
Berlin, Heidelberg, Magdeburg
2021-06-25
Active, closed
Merck Sharp & Dohme LLC
Phase 2
302
Munich, Marburg, Essen, Dresden, Magdeburg, Berlin, Hamburg
2021-06-25
Active, closed
Janssen Research & Development, LLC
Phase 3
1,054
Berlin, Hamburg, Herne, Magdeburg, Mainz, Ratingen
2021-06-17
Active, closed
HistoSonics, Inc.
Not applicable
24
Braunschweig, Magdeburg
2021-06-04
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Berlin, Bochum, Bonn, Frankfurt, Hanover, Leipzig, Lübeck, Magdeburg
2021-04-01
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Hanover, Bonn, Berlin, Erlangen, Kiel, Leipzig, Magdeburg, Tübingen
2020-12-18
Recruiting
HIPEC + FLOT vs. FLOT Alone in Patients With Gastric Cancer and GEJ (PREVENT)
NCT04447352Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
DrugsCalciumfolinat·Leucovorin·Adrucil·Docetaxel
Krankenhaus Nordwest
Phase 3
200
Aachen, Dresden, Frankfurt, Halle, Leipzig, Ludwigsburg, Lübeck, Magdeburg
2020-12-17
Recruiting
Robotic Curriculum for Young Surgeons
NCT05960539Robotic Surgery
Otto-von-Guericke University Magdeburg
Observational
500
Magdeburg
2020-05-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Tübingen, Düsseldorf, Essen, Dresden, Magdeburg, Jena, Berlin, Hamburg
2020-02-27
Active, closed
Loxo Oncology, Inc.
Phase 3
291
München, Würzburg, Hanover, Essen, Mainz, Magdeburg, Berlin, Hamburg
2020-02-11
Active, closed
Goethe University
Phase 2
180
Darmstadt, Dresden, Freiburg im Breisgau, Essen, Kiel, Leipzig, Magdeburg, Mainz
2020-01-07
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
140
Magdeburg
2019-12-05
Recruiting
Dr. Rebecca Schule
Observational
2,000
Bonn, Erlangen, Essen, Göttingen, Heidelberg, Lübeck, Magdeburg, München
2019-10-14
Recruiting
Stroke Thrombectomy and Aneurysm Registry
NCT04994756Stroke, Thromboses, Intracranial, Aneurysm, Brain
Medical University of South Carolina
Observational
40,000
Göttingen, Magdeburg
2019-09-17
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Stuttgart, Tübingen, Erlangen, Munich, Würzburg, Bonn, Dresden, Magdeburg
2019-07-24
Active, closed
High Frequency Imaging in Cerebral Amyloid Angiopathy
NCT06128824Cerebral Amyloid Angiopathy
Martin Dichgans
Observational
75
Bonn, Magdeburg, Munich
2019-03-19
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Braunschweig, Duisburg, Homburg, Magdeburg, Münster, Nürtingen
2019-01-25
Active, closed
Evidence For Fusion In Spine With Orthoss®
NCT03853356Lumbar Spondylolisthesis Involving L4-L5, Lumbar Spondylolisthesis Involving L5-S1, Lumbar Spinal Stenosis, Lumbar Disc Degeneration
Geistlich Pharma AG
Observational
65
Augsburg, Düsseldorf, Magdeburg
2019-01-18
Recruiting
Nationwide Uniform Scientific Evaluation of Flexible and Integrated Treatment Projects From 2022 Onwards
NCT05855720Mental Health, Cross-sectoral Treatment, Flexible and Integrated Treatment, FIT
Technische Universität Dresden
Observational
30,000
Magdeburg
2019-01-01
Active, closed
AstraZeneca
Phase 3
1,063
Bergisch Gladbach, Bonn, Cologne, Erlangen, Göttingen, Herne, Jena, Magdeburg
2018-11-16
Active, closed
Exelixis
Phase 3
187
Tübingen, Würzburg, Marburg, Hanover, Dresden, Magdeburg, Aachen, Bonn
2018-10-05
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Munich, München, Mainz, Dresden, Leipzig, Halle, Magdeburg, Berlin
2018-06-21
Active, closed
BioMarin Pharmaceutical
Phase 3
119
Magdeburg, Münster
2017-12-12
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Berlin, Freiburg im Breisgau, Magdeburg
2017-09-25
Active, closed
ITM Solucin GmbH
Phase 3
324
Bad Berka, Berlin, Bonn, Erlangen, Essen, Hamburg, Magdeburg, Marburg
2017-02-02
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Aachen, Berlin, Düsseldorf, Frankfurt, Hanover, Leipzig, Magdeburg, Mainz
2016-12
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Dresden, Jena, Aachen, Hamburg, Magdeburg, Mainz, Ulm
2015-03-05
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Berlin, Dresden, Essen, Giessen, Heidelberg, Homburg/Saar, Magdeburg, Marburg
2013-09-09
Recruiting
Javier P. Gisbert
Observational
10,000
Magdeburg
2013-06
Active, closed
Bristol-Myers Squibb
Observational
2,555
Heidelberg, Hamm, Aschaffenburg, Berlin, Dresden, Magdeburg, München, Rostock
2012-06-13
Active, closed
Observational Study on Determinants of Dementia After Stroke
NCT01334749Ischemic Stroke, Hemorrhagic Stroke
Ludwig-Maximilians - University of Munich
Observational
736
Munich, Berlin, Bonn, Göttingen, Magdeburg
2011-04
Recruiting
Sporadic Degenerative Ataxia With Adult Onset: Natural History Study
NCT02701036Late Onset Sporadic Cerebellar Ataxia
Ataxia Study Group
Observational
300
Berlin, Bonn, Essen, Frankfurt, Hamburg, Magdeburg, München, Rostock
2010-04
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Erlangen, Heidelberg, Homburg, Magdeburg, Oldenburg
2008-12-09
Rows per page Showing 1–94 of 94
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/magdeburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 94 of those studies with a site in Magdeburg.

How many clinical trials are recruiting in Magdeburg?

38 of the 94 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 51 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Magdeburg), 94 studies
PhaseStudiesRecruitingShare
Phase 3391041.5%
Observational221523.4%
Phase 214414.9%
Not applicable737.4%
Phase 1525.3%
Phase 4323.2%
Phase 1/2212.1%
Phase 2/3212.1%

Most active sponsors

Lead sponsors with the most studies (Magdeburg)
Lead sponsorStudiesRecruiting
AstraZeneca52
BioMarin Pharmaceutical52
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company51
Bristol-Myers Squibb41
Janssen Research & Development, LLC40
Pfizer43
Merck Sharp & Dohme LLC30
Novartis Pharmaceuticals31
Novo Nordisk A/S31
Artcline GmbH22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.